CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	May 31, 2025	May 31, 2024	Aug. 31, 2024	Aug. 31, 2023
Operating Activities
Net (loss) earnings	$ 64,668	$ 61,333
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	2,535
Net Earnings from Continuing Operations	64,668	58,798
Impairment & divestiture (benefits) charges	0	147
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	10,706	9,970
Stock-based compensation expense	9,525	8,299
Benefit for deferred income taxes	3,782	(4,297)
Amortization of debt issuance costs	440	438
Other Noncash Income (Expense)	1,059	3,300
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	(3,971)	(10,450)
Inventories	(13,058)	(3,769)
Trade accounts payable	(973)	(8,972)
Prepaid expenses and other assets	(9,189)	(5,568)
Income tax accounts	(6,594)	8,305
Accrued compensation and benefits	1,830	(8,542)
Other accrued liabilities	(2,195)	(8,262)
Cash provided by (used in) operating activities, Continuing Operations	56,030	39,544
Cash (used in) provided by operating activities, Discontinued Operations	0	(2,586)
Cash (Used in) Provided By Operating Activities	56,030	36,958
Investing Activities
Capital expenditures	(16,360)	(4,970)
Payments to Acquire Businesses, Net of Cash Acquired	26,744	0
Cash used in investing activities, Continuing Operations	(43,104)	(7,505)
Cash Provided by Investing Activities	(43,104)	(7,505)
Financing Activities
Borrowings on Revolving Credit	14,421	48,000
Principal Repayment on Revolving Credit Facility	(14,421)	(64,000)
Principal repayments on term loan	(3,750)	(2,500)
Taxes paid related to the net share settlement of equity awards	(7,409)	(3,235)
Stock option exercises & other	1,949	5,200
Cash dividend	(2,167)	(2,178)
Net Cash Used in Financing Activities, Continuing Operations	(39,971)	(51,404)
Cash used in financing activities	(39,971)	(51,404)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(26,588)	(22,053)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	457	(102)
Payments for Repurchase of Common Stock	(28,594)	(32,691)
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	140,506	132,362	$ 167,094	$ 154,415
Purchase of assets	0	(1,402)
Working capital adjustment from the sale of business assets	0	(1,133)
Increase in Receivable Reserve	$ 0	$ 147